Certara Inc. (CERT) News

Certara Inc. (CERT): $17.41

0.16 (+0.93%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add CERT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#98 of 380

in industry

Filter CERT News Items

CERT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CERT News Highlights

  • For CERT, its 30 day story count is now at 2.
  • Over the past 7 days, the trend for CERT's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest CERT News From Around the Web

Below are the latest news stories about CERTARA INC that investors may wish to consider to help them evaluate CERT as an investment opportunity.

Reasons to Invest in Certara (CERT)

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was up 11.20% in the first quarter compared to the Russell 2000 Growth Index’s return of 6.07%. The strong performance of holdings in the Information Technology (IT), Industrials, and […]

Yahoo | May 16, 2023

Q1 2023 Certara Inc Earnings Call

Q1 2023 Certara Inc Earnings Call

Yahoo | May 9, 2023

Certara, Inc. (CERT) Matches Q1 Earnings Estimates

Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 8, 2023

Certara Reports First Quarter 2023 Financial Results

Reiterates 2023 Financial GuidancePRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2023. First Quarter Highlights: Revenue was $90.3 million, compared to $81.6 million in the first quarter of 2022, representing growth of 11% over the first quarter of 2022 on a reported basis and 13% at constant currency.Net income was $1.4 million, compared to $2.2 million in

Yahoo | May 8, 2023

Guardant Health (GH) Expected to Beat Earnings Estimates: Should You Buy?

Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 2, 2023

Factors to Note Ahead of Atlassian's (TEAM) Q3 Earnings Release

Atlassian's (TEAM) Q3 results are likely to reflect the benefits of increased demand for its solutions amid accelerated digital transformations and cloud adoptions.

Yahoo | May 2, 2023

DraftKings (DKNG) to Report Q1 Earnings: What's in Store?

DraftKings' (DKNG) first-quarter 2023 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.

Yahoo | May 1, 2023

Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 1, 2023

The Zacks Analyst Blog Highlights Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara

Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara are included in this Analyst Blog.

Yahoo | May 1, 2023

5 Must-Buy High-Flying Mid-Cap Stocks Ahead of Q1 Earnings

We have narrowed our search to five stocks that are set to report first-quarter 2023 earnings results. These are: SHAK, WING, AMK, PRI and CERT.

Yahoo | April 28, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6481 seconds.